Hans-Jürgen Teschendorf

This inventor holds 13 USPTO granted patents. Top assignees: Abbott Laboratories Corporation, Basf Aktiengesellschaft. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Jürgen Teschendorf. Retrieved from https://idiyas.com/inventor/hans-janduumlrgen-teschendorf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13

% Patents Active = 84.6

Average Co-Inventor Count = 6.7

ph-index = 6

Forward Citations = 91(Granted Patents)

Location History:

Dudenhofen, DE (2001 - 2002)
Dundenhofen, DE (2002)

Company Filing History:

8 out of 4,190

Abbott Laboratories Corporation

patents

5 out of 10,816

Basf Aktiengesellschaft

patents

Years Active: 2001-2002

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6472392 - Triazole compounds and the use thereof as dopamine-D3 -ligands (2002-10-29),

2. 6458821 - N-substituted azabicycloheptane derivatives, production and use thereof (2002-10-01),

3. 6444674 - Substituted pyrimidine compounds and the use thereof (2002-09-03),

4. 6414157 - 3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use (2002-07-02),

5. 6407109 - Pyrrolyl tetrahydroquinoxalin diones, their production and use in the treatment of diseases (2002-06-18),

6. 6403593 - Triazole compounds and the use thereof (2002-06-11),

7. 6355647 - 3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use (2002-03-12),

8. 6352981 - Substituted AZA- and diazacycloheptane and -cyclooctane (2002-03-05),

9. 6346622 - 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5HT1B and 5-HT1D) (2002-02-12),

10. 6342604 - Substitute pyrimidine compounds and the use thereof (2002-01-29),

11. 6300354 - N-substituted azabicycloheptane derivatives, production and use thereof (2001-10-09),

12. 6222034 - 3-substituted pyrido[4′,3′:4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use (2001-04-24),

13. 6214822 - Substituted aza and diazacycloheptane and cyclooctane compounds and their use (2001-04-10),

Title: Hans-Jürgen Teschendorf: A Trailblazer in Innovation

Introduction

Hans-Jürgen Teschendorf, a visionary inventor based in Dudenhofen, DE, has left an indelible mark in the realm of innovation with his relentless pursuit of excellence. With a total of 13 patents to his name, Teschendorf continues to inspire generations of inventors to push the boundaries of what is achievable.

Latest Patents

Among his latest patents are groundbreaking inventions such as "Triazole compounds and the use thereof as dopamine-D3-ligands" and "N-substituted azabicycloheptane derivatives, production, and use thereof." These innovations showcase Teschendorf's commitment to pioneering new solutions in the field.

Career Highlights

Having worked in prominent companies such as Abbott Laboratories Corporation and BASF Aktiengesellschaft, Teschendorf has honed his skills and expertise in driving innovation forward. His contributions have not only reshaped industries but have also set new standards for aspiring inventors worldwide.

Collaborations

Throughout his illustrious career, Teschendorf has had the privilege of collaborating with talented individuals such as Karsten M. Wicke and Liliane Unger. These partnerships have led to the development of groundbreaking technologies that have made a significant impact on society.

Conclusion

In conclusion, Hans-Jürgen Teschendorf's dedication to innovation and his unwavering pursuit of excellence have solidified his position as a prominent figure in the world of inventors. His work serves as a testament to the power of perseverance and ingenuity in driving positive change and shaping the future of innovation.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]